Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sage Therapeutics

6.61
-0.1400-2.07%
Post-market: 6.59-0.0200-0.30%18:13 EDT
Volume:877.66K
Turnover:5.84M
Market Cap:413.92M
PE:-1.14
High:6.80
Open:6.79
Low:6.58
Close:6.75
Loading ...

Cautious Outlook for SAGE Therapeutics Amid Strategic Uncertainty and Financial Challenges

TIPRANKS
·
20 Apr

Sage Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, April 29, 2025

Business Wire
·
15 Apr

RBC Raises Price Target on SAGE Therapeutics to $7 From $6, Keeps Sector Perform, Speculative Risk

MT Newswires Live
·
03 Apr

US Stocks Likely To Open Mixed: 'Expect Volatility. Buckle Up,' Says Expert

Benzinga
·
27 Mar

Sage Therapeutics (SAGE) Up 7.4% Since Last Earnings Report: Can It Continue?

Zacks
·
13 Mar

Sage Therapeutics resumed with an Underperform at BofA

TIPRANKS
·
11 Mar

SAGE Therapeutics Announces CMO Resignation and Interim Appointment

TIPRANKS
·
05 Mar

BRIEF-SAGE Therapeutics Announces Research And Development Leadership Transition

Reuters
·
05 Mar

Sage Therapeutics Announces R&D Leadership Transition

THOMSON REUTERS
·
05 Mar

Sage Therapeutics Announces R&D Leadership Transition

Business Wire
·
05 Mar

Sage Therapeutics, Inc. (SAGE): Among the Best Psychedelic Stocks to Buy in 2025

Insider Monkey
·
02 Mar

SAGE Therapeutics (SAGE) Gets a Hold from Truist Financial

TIPRANKS
·
13 Feb

SAGE Therapeutics Faces Legal Challenges: Potential Impact on Financial Stability and Growth

TIPRANKS
·
13 Feb

Hold Rating for SAGE Therapeutics: Inventory Challenges and Strategic Prospects

TIPRANKS
·
13 Feb

SAGE Therapeutics’ Earnings Call: ZURZUVAE’s Success Amid Challenges

TIPRANKS
·
13 Feb

Sage Therapeutics' Q4 Earnings Miss Mark, Revenues Plunge Y/Y

Zacks
·
13 Feb

Sage Therapeutics Is Maintained at Sector Outperform by Scotiabank

Dow Jones
·
13 Feb

Sage Therapeutics price target lowered to $12 from $14 at Scotiabank

TIPRANKS
·
12 Feb

Sage Therapeutics Price Target Cut to $12.00/Share From $14.00 by HC Wainwright & Co.

Dow Jones
·
12 Feb

SAGE Therapeutics (SAGE) Gets a Buy from Scotiabank

TIPRANKS
·
12 Feb